<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016635"><a href="http://purl.obolibrary.org/obo/MONDO_0016635">MONDO:0016635</a></h3>
<p><strong>Label:</strong> rare thrombotic disorder due to a platelet anomaly</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0013794">MONDO:0013794</a> (thrombocythemia 3), <a href="http://purl.obolibrary.org/obo/MONDO_0005029">MONDO:0005029</a> (essential thrombocythemia), <a href="http://purl.obolibrary.org/obo/MONDO_0011173">MONDO:0011173</a> (thrombocythemia 2), <a href="http://purl.obolibrary.org/obo/MONDO_0018896">MONDO:0018896</a> (thrombotic thrombocytopenic purpura), <a href="http://purl.obolibrary.org/obo/MONDO_0019111">MONDO:0019111</a> (familial thrombocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0008554">MONDO:0008554</a> (thrombocythemia 1), <a href="http://purl.obolibrary.org/obo/MONDO_0016636">MONDO:0016636</a> (rare thrombotic disorder due to a constitutional platelet anomaly), <a href="http://purl.obolibrary.org/obo/MONDO_0016637">MONDO:0016637</a> (rare thrombotic disorder due to an acquired platelet anomaly),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_614521">OMIM:614521</a>, <a href="http://purl.obolibrary.org/obo/OMIM_187950">OMIM:187950</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3318">Orphanet:3318</a>, <a href="http://www.orpha.net/ORDO/Orphanet_248404">Orphanet:248404</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300331">OMIM:300331</a>, <a href="http://purl.obolibrary.org/obo/OMIM_274150">OMIM:274150</a>, <a href="http://www.orpha.net/ORDO/Orphanet_248401">Orphanet:248401</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601977">OMIM:601977</a>, <a href="http://www.orpha.net/ORDO/Orphanet_71493">Orphanet:71493</a>, <a href="http://www.orpha.net/ORDO/Orphanet_54057">Orphanet:54057</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 58.71%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 55.36%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 53.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0025408">HP:0025408</a> (Abnormal spleen morphology) 53.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001744">HP:0001744</a> (Splenomegaly) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 53.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001743">HP:0001743</a> (Abnormality of the spleen) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 53.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0003271">HP:0003271</a> (Visceromegaly) and <a href="http://purl.obolibrary.org/obo/HP_0025408">HP:0025408</a> (Abnormal spleen morphology) 53.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001438">HP:0001438</a> (Abnormality of abdomen morphology) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0025408">HP:0025408</a> (Abnormal spleen morphology) 53.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001872">HP:0001872</a> (Abnormality of thrombocytes) 51.55%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0003271">HP:0003271</a> (Visceromegaly) 47.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001438">HP:0001438</a> (Abnormality of abdomen morphology) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 47.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 45.82%</li>
</ul>
</body>
</html>
